scholarly journals WEIGHT LOSS WITH OR WITHOUT INTRAGASTRIC BALLOON CAUSES DIVERGENT EFFECTS ON GHRELIN CELL EXPRESSION

2020 ◽  
Author(s):  
E.M.H. Mathus‐Vliegen ◽  
Spångeus A ◽  
Walter S ◽  
Ericson A
Keyword(s):  
Weight Loss ◽  
Intragastric Balloon ◽  
Cell Expression

Assessment of the Effect of Dietary Modifications and Bioenteric Intragastric Balloon Treatment on the Changes of Some Morphological and Biochemical Parameters in Obese Patients

2018 ◽  
Vol 73 (4) ◽  
pp. 290-301 ◽  
Author(s):  
Edyta Balejko ◽  
Jerzy Balejko ◽  
Dominika Plust
Keyword(s):  
Fatty Acids ◽  
Weight Loss ◽  
Body Weight ◽  
Body Mass ◽  
Intragastric Balloon ◽  
World Health ◽  
Anthropometric Measurement ◽  
High Density Lipoproteins ◽  
Common Disease ◽  
High Tendency

Obesity is the most common disease of affluence of the XXI century. According to WHO (World Health Organization), it is defined as a chronic metabolic disorder manifested by excessive accumulation of adipose tissue with high tendency for familial occurrence. According to WHO, obesity reaches epidemic proportions in many countries. High BMI (Body Mass Index) correlates with coexisting diseases. Traditional dietetic treatment often does not bring any results. A form of conservative (non-surgical) support for patients in fighting with obesity is the reduction of stomach volume by bioenteric intragastric balloon (BIB) treatment. The aim of the work was to develop a diet with anti-inflammatory properties, well-tolerated by the patients after BIB treatment. An American diet was modified by changing the composition of fatty acids, increasing anti-oxidative potential and adding synbiotics for patients treated with BIB. Chemical analysis of reconstructed food ratios of recommended diet was performed, analysing the content of micronutrients, composition of fatty acids, antioxidative capacity, reducing power and the content of polyphenols. Improvement in anthropometric measurement results and satisfying body weight loss were obtained, while preserving fat-free body mass. Improvement in the parameters of lipid metabolism was also observed, that is, decrease in total CH (cholesterol) and TG (triglycerides), and normalized concentration of HDL (high density lipoproteins) and LDL (low density lipoproteins) fractions. Reduced concentration of glucose in blood and lower blood pressure was also noted. Performed study confirms the effectiveness of complex treatment with BIB and properly adjusted individualized diet. Observations and own experience allow to deduce that patients who resign from systematic contact with a dietician cannot maintain reduced body weight. Abandoning previous habits is the only way to maintain the effect of weight loss. Most importantly, the change in patients’ awareness and consequent behaviour in the future are crucial. Even though genes may contribute to obesity, environmental factors mainly determine the possibility of the disease to occur. Therefore, the change of patients’ lifestyle after body weight reduction will decide on their fate.

scholarly journals Life-threatening visceral complications after intragastric balloon insertion: Is the device, the patient or the doctor to blame?

2019 ◽  
Vol 07 (02) ◽  
pp. E122-E129 ◽  
Author(s):  
George Stavrou ◽  
Georgia Tsaousi ◽  
Katerina Kotzampassi
Keyword(s):  
Weight Loss ◽  
Bowel Obstruction ◽  
Esophageal Perforation ◽  
Intragastric Balloon ◽  
Gastric Perforation ◽  
Low Cost ◽  
Invasive Procedure ◽  
Safe Procedure ◽  
Bariatric Endoscopy ◽  
Mandatory Education

Abstract Background and aim Intragastric balloon placement is established as a safe, relatively low-cost and well-tolerated minimally invasive procedure for weight loss, giving encouraging results under the strict prerequisite that the obese patient will enroll in a medically supervised weight loss program. This retrospective study reviews already published cases of severe visceral complications for the purpose of assigning responsibility to the device, the patient, or the doctor. Methods We reviewed PubMed and Scopus archived publications describing intragastric balloon (BIB/Orbera)-related severe visceral complications, i. e. perforations and obstructions. Results Twenty-two cases of gastric perforation, two cases of esophageal perforation and 10 cases of bowel obstruction were found. For the gastric perforation the endoscopist was responsible in nine cases, the patient in four, and the balloon itself in nine. For the two cases of esophageal perforation, the endoscopists were responsible, while for the 12 cases of bowel obstruction, the patient was responsible for seven and the device for the other five cases. Conclusion BIB/Orbera balloon insertion remains a safe procedure, with a minimum of complications related to hollow viscera. Mandatory education and accreditation of physicians dealing with bariatric endoscopy and strict supervision of the obese individuals, while living with the balloon, will eliminate such complications.

176 PIVOTAL RANDOMIZED-CONTROLLED TRIAL OF THE ADJUSTABLE (SPATZ-3) INTRAGASTRIC BALLOON SYSTEM FOR WEIGHT LOSS

2019 ◽  
Vol 89 (6) ◽  
pp. AB58-AB59 ◽  
Author(s):  
Barham K. Abu Dayyeh ◽  
Mark D. Noar ◽  
Tom Lavin ◽  
Hisham Hussan ◽  
Christopher G. Chapman ◽  
...  
Keyword(s):  
Weight Loss ◽  
Randomized Controlled Trial ◽  
Intragastric Balloon ◽  
Controlled Trial ◽  
Randomized Controlled ◽  
Balloon System

Sa2008 Effect of Pharmacotherapy on Weight Loss Maintenance After Obesity Treatment With the Intragastric Balloon: an Initial Single-Center Report

2017 ◽  
Vol 85 (5) ◽  
pp. AB273
Author(s):  
Hoda C. Kadouh ◽  
Michael Camilleri ◽  
Manpreet Mundi ◽  
Meera Shah ◽  
Maria L. Collazo-Clavell ◽  
...  
Keyword(s):  
Weight Loss ◽  
Intragastric Balloon ◽  
Weight Loss Maintenance ◽  
Obesity Treatment ◽  
Single Center ◽  
Center Report

scholarly journals Outcomes following Serial Intragastric Balloon Therapy for Obesity and Nonalcoholic Fatty Liver Disease in a Single Centre

2017 ◽  
Vol 2017 ◽  
pp. 1-8 ◽  
Author(s):  
Vi Nguyen ◽  
Jiawei Li ◽  
Jaslyn Gan ◽  
Paul Cordero ◽  
Shuvra Ray ◽  
...  
Keyword(s):  
Weight Loss ◽  
Liver Disease ◽  
Fatty Liver ◽  
Nonalcoholic Fatty Liver Disease ◽  
Fatty Liver Disease ◽  
Intragastric Balloon ◽  
Nonalcoholic Fatty Liver ◽  
Hepatic Transaminases ◽  
Alternative Treatment Option ◽  
Baseline Weight

Background. The incidence of nonalcoholic fatty liver disease (NAFLD) continues to parallel the rise in obesity rates. Endobariatric devices such as the intragastric balloon (IGB) may provide an alternative treatment option.Methods. Outcomes following IGB treatment in 135 patients with obesity and NAFLD (mean baseline weight 117.9 kg; BMI 41.7 kg/m2; HOMA-IR 3.6) were retrospectively examined. Clinical, anthropometric, and biochemical changes were analysed at six months and after consecutive treatment with two and three serial IGBs.Results. After six months, significant changes were seen with weight and BMI (mean reductions of 11.3 kg and 4.1 kg/m2, resp.,p<0.01for both). Significant improvements were also seen with ALT, GGT, and HOMA-IR, with all changes corresponding with weight loss. Forty-eight patients received two IGBs, and 20 were treated with three serial IGBs. The greatest amount of total weight loss was observed after the first 6 months (mean weight lost 7.4 kg, versus 3.6 kg and 1.9 kg with two and three IGBs, resp.).Conclusions. IGB therapy is an effective, alternative nonsurgical means for weight loss in the management of obesity and NAFLD over the short term, with greatest outcomes observed after six months. Improvements in insulin resistance and hepatic transaminases correlated with weight change.

Displacement of the Intragastric Balloon from the Fundus to the Antrum Results in Enhanced Weight Loss

2018 ◽  
Vol 28 (8) ◽  
pp. 2374-2378 ◽  
Author(s):  
Theodosios S Papavramidis ◽  
George Stavrou ◽  
Pyrros Papakostas ◽  
Vasilis Grosomanidis ◽  
Smaro Kokkota ◽  
...  
Keyword(s):  
Weight Loss ◽  
Intragastric Balloon
Sign in / Sign up

Export Citation Format

Share Document